Stemrim Information

StemRIM is a drug discovery research and development-oriented biotech company originating from Osaka University. It was established in 2006 with the aim of developing a myelomulti-active stem cell recruitment factor as a pharmaceutical product, which was identified by Professor Tamai and his colleagues at the Graduate School of Medicine, Osaka University. Since then, through joint research with Osaka University, StemRIM has been consistently worked on the development of "regeneration-inducing medicine", which is medicine promoting functional tissue regeneration and enabling the treatment of intractable diseases. StenRIM is continuing to take on the challenge of becoming a world-leading bioventure with the corporate mission of "overcoming intractable diseases with regeneration-inducing medicine.